Mechanical stretch induces monocyte chemoattractant activity via an NF-κB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: Inhibition by rosiglitazone

Journal of the American Society of Nephrology

Volumn 16, Issue 3, 2005, Pages 688-696

  Gruden, Gabriella ^a,b   Setti, Giorgia ^a   Hayward, Anthea ^a   Sugden, David ^a   Duggan, Sara ^a   Burt, Davina ^a   Buckingham, Robin E ^a   Gnudi, Luigi ^a   Viberti, Giancarlo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Department of Internal Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALBUMIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; ROSIGLITAZONE; ANTIDIABETIC AGENT; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG INHIBITION; GLOMERULUS CAPILLARY; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MACROPHAGE; MESANGIUM CELL; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; MECHANICAL STRESS; MESANGIUM; METABOLISM; PHYSIOLOGY; SECRETION;

CELLS, CULTURED; CHEMOKINE CCL2; GENE EXPRESSION; GLOMERULAR MESANGIUM; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; I-KAPPA B PROTEINS; NF-KAPPA B; STRESS, MECHANICAL; THIAZOLIDINEDIONES;

EID: 20544452357     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004030251     Document Type: Article

References (53)

1. Hostetter TH, Rennke HG, Brenner BM: The case for intra-renal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375-380, 1982
2. Riser BL, Cortes P, Zhao X, Bernstein J, Dumier F, Narins RG: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 90: 1932-1943, 1992
3. Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, Gnudi L, Viberti GC: Mechanical stretch-induced fibronectin and transforming growth factor-β1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49: 655-661, 2000
4. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K: Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58: 684-690, 2000
5. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J, Bruneval P: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49: 466-475, 2000
6. Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL, Brenner BM, MacKenzie HS: Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 56: 1037-1048, 1999
7. Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS: Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58: 1664-1676, 2000
8. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H: Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52: 2586-2593, 2003
9. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, De Lourdes Noronha I, Zatz R: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63: 209-216, 2003
10. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
11. Bakris G, Viberti G, Weston WM, Heise M, Porter LE, Freed MI: Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens 17: 7-12, 2003
12. Yamashita H, Nagai Y, Takamura T, Nohara E, Kobayashi K: Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metabolism 51: 403-408, 2002
13. McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH: Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int 58: 2341-2350, 2000
14. Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R: Thiazolidinedione compounds ameliorate glomerular d ysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 49: 1022-1032, 2000
15. Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC, Clapham JC: Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47: 1326-1334, 1998
16. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB: PPAR-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59: 1899-1910, 2001
17. Yoshida K, Kohzuki M, Xu HL, Wu XM, Kamimoto M, Sato T: Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure. J Hypertens 19: 503-510, 2001
18. Jiang C, Ting AT, Seed B: PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998
19. Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH: In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 104: 2588-2594, 2000
20. Nicholas SB, Kawano Y, Wakino S, Collins AR, Hsueh WA: Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells. Hypertension 37: 722-727, 2001
21. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM: PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7: 48-52, 2001
22. Striker GE, Striker LJ: Biology of disease: Glomerular cell culture. Lab Invest 53: 122-131, 1985
23. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G: Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction. Proc Natl Acad Sci U S A 94: 12112-12116, 1997
24. Banes AJ, Gilbert J, Taylor D, Monbureau O: A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. J Cell Sci 75: 35-42, 1985
25. Drumond MC, Deen WM: Analysis of pulsatile pressures and flows in glomerular filtration. Am J Physiol 261: F409-F419, 1991
26. Hashimoto Y, Ideura T, Yoshimura A, Koshikawa S: Autoregulation of renal blood flow in streptozocin-induced diabetic rats. Diabetes 38: 1109-1113, 1989
27. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J: Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270: 14255-14258, 1995
28. Rovin BH, Dickerson JA, Tan LC, Hebert CA: Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney Int 48: 1263-1271, 1995
29. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161: 430-439, 1998
30. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD: A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389, 1999
31. Wang N, Verna L, Chen NG, Chen J, Li H, Forman BM, Stemerman MB: Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277: 34176-34181, 2002
32. Suda T, Osajima A, Tamura M, Kato H, Iwamoto M, Ota T, Kanegae K, Tanaka H, Anai H, Kabashima N, Okazaki M, Nakashima Y: Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 60: 1705-1715, 2001
33. Wung BS, Cheng JJ, Chao YJ, Lin J, Shyy YJ, Wang DL: Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells. Am J Physiol 270: H1462-H1468, 1996
34. Capers Q 4th, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30: 1397-1402, 1997
35. Grandaliano G, Valente AJ, Rozek MM, Abboud HE: Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells. J Lab Clin Med 123: 282-289, 1994
36. Rovin BH, Yoshiumura T, Tan L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148: 2148-2153, 1992
37. Goppelt-Struebe M, Stroebel M: Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1. FEBS Lett 374: 375-378, 1995
38. Kito K, Nishida K: Nonrequirement of continuous stimulation with MCP-1 for cell migration and determination of directional migration by initial stimulation with chemokine. Exp Cell Res 281: 157-166, 2002
39. Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, Cha DR, Ha H: A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79: 33-37, 1998
40. Nishikawa T, Edelstein D, Brownlee M: The missing link: A single unifying mechanism for diabetic complications. Kidney Int Suppl 77: S26-S30, 2000
41. Hishikawa K, Oemar BS, Yang Z, Luscher TF: Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res 81: 797-803, 1997
42. Inoh H, Ishiguro N, Sawazaki S, Amma H, Miyazu M, Iwata H, Sokabe M, Naruse K: Uni-axial cyclic stretch induces the activation of transcription factor nuclear factor κB in human fibroblast cells. FASEB J 16: 405-407, 2002
43. Thompson-Culkin K, Zussman B, Miller AK, Freed MI: Pharmacokinetics of rosiglitazone in patients with end-stage renal disease. J Int Med Res 30: 391-399, 2002
44. Chang PC, Chen TH, Chang CJ, Hou CC, Chan P, Lee HM: Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65: 1664-1675, 2004
45. Bhagavathula N, Nerusu KC, Lal A, Ellis CN, Chittiboyina A, Avery MA, Ho CI, Benson SC, Pershadsingh HA, Kurtz TW, Varani J: Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. J Invest Dermatol 122: 130-139, 2004
46. Bishop-Bailey D, Warner TD: PPARγ ligands induce prostaglandin production in vascular smooth muscle cells: Indomethacin acts as a peroxisome proliferator-activated receptor-γ antagonist. FASEB J 17: 1925-1927, 2003
47. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998
48. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: Mediators of glomerular pressure injury. Kidney Int 45: S11-S16, 1994
49. Cortes P, Zhao X, Riser BL, Narins RG: Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol 363: F356-F370, 1996
50. Pawluczyk IZ, Harris KP: Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells. Kidney Int 54: 62-70, 1998
51. Haraguchi K, Shimura H, Onaya T: Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)γ activators. Clin Exp Nephrol 7: 27-32, 2003
52. Panzer U, Schneider A, Guan Y, Reinking R, Zahner G, Harendza S, Wolf G, Thaiss F, Stahl RAK: Effect of different PPARγ-agonists on MCP-1 expression and monocyte infiltration in experimental glomerulonephritis. Kidney Int 62: 455-464, 2002
53. Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H: Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism 50: 1193-1196, 2001